Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Global Outlook and Forecast 2023-2028

Report ID: 1572517 | Published Date: Jan 2025 | No. of Page: 70 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Overall Market Size
    2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size: 2021 VS 2028
    2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales: 2017-2028
3 Company Landscape
    3.1 Top Non-steroidal Anti-inflammatory Drugs (NSAID) Players in Global Market
    3.2 Top Global Non-steroidal Anti-inflammatory Drugs (NSAID) Companies Ranked by Revenue
    3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Companies
    3.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Companies
    3.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Players in Global Market
        3.8.1 List of Global Tier 1 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies
        3.8.2 List of Global Tier 2 and Tier 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Markets, 2021 & 2028
        4.1.2 Salicylates
        4.1.3 Propionic acid derivatives
        4.1.4 Acetic acid derivatives
        4.1.5 Enolic acid (Oxicam) derivatives
        4.1.6 Anthranilic acid derivatives (Fenamates)
        4.1.7 Selective COX-2 inhibitors (Coxibs)
        4.1.8 Sulfonanilides
    4.2 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue & Forecasts
        4.2.1 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2022
        4.2.2 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2023-2028
        4.2.3 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
    4.3 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales & Forecasts
        4.3.1 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2022
        4.3.2 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2023-2028
        4.3.3 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
    4.4 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2021 & 2028
        5.1.2 Human
        5.1.3 Animals
        5.1.4 Others
    5.2 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue & Forecasts
        5.2.1 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2022
        5.2.2 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2023-2028
        5.2.3 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
    5.3 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales & Forecasts
        5.3.1 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2022
        5.3.2 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2023-2028
        5.3.3 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
    5.4 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2021 & 2028
    6.2 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue & Forecasts
        6.2.1 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2022
        6.2.2 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2023-2028
        6.2.3 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
    6.3 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales & Forecasts
        6.3.1 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2022
        6.3.2 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2023-2028
        6.3.3 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2028
        6.4.2 By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2028
        6.4.3 US Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
        6.4.4 Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
        6.4.5 Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2028
        6.5.2 By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2028
        6.5.3 Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
        6.5.4 France Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
        6.5.5 U.K. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
        6.5.6 Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
        6.5.7 Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
        6.5.8 Nordic Countries Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
        6.5.9 Benelux Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2028
        6.6.2 By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2028
        6.6.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
        6.6.4 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
        6.6.5 South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
        6.6.6 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
        6.6.7 India Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2028
        6.7.2 By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2028
        6.7.3 Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
        6.7.4 Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2017-2028
        6.8.3 Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
        6.8.4 Israel Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
        6.8.5 Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
        6.8.6 UAE Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Bayer
        7.1.1 Bayer Corporate Summary
        7.1.2 Bayer Business Overview
        7.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
        7.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
        7.1.5 Bayer Key News
    7.2 Ecotrin
        7.2.1 Ecotrin Corporate Summary
        7.2.2 Ecotrin Business Overview
        7.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
        7.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
        7.2.5 Ecotrin Key News
    7.3 Generic
        7.3.1 Generic Corporate Summary
        7.3.2 Generic Business Overview
        7.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
        7.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
        7.3.5 Generic Key News
    7.4 St. Joseph
        7.4.1 St. Joseph Corporate Summary
        7.4.2 St. Joseph Business Overview
        7.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
        7.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
        7.4.5 St. Joseph Key News
    7.5 Elanco
        7.5.1 Elanco Corporate Summary
        7.5.2 Elanco Business Overview
        7.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
        7.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
        7.5.5 Elanco Key News
    7.6 Zoetis
        7.6.1 Zoetis Corporate Summary
        7.6.2 Zoetis Business Overview
        7.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
        7.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
        7.6.5 Zoetis Key News
    7.7 Boehringer Ingelheim
        7.7.1 Boehringer Ingelheim Corporate Summary
        7.7.2 Boehringer Ingelheim Business Overview
        7.7.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
        7.7.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
        7.7.5 Boehringer Ingelheim Key News
    7.8 Merial
        7.8.1 Merial Corporate Summary
        7.8.2 Merial Business Overview
        7.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
        7.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
        7.8.5 Merial Key News
    7.9 Merck Animal Health
        7.9.1 Merck Animal Health Corporate Summary
        7.9.2 Merck Animal Health Business Overview
        7.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
        7.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2017-2022)
        7.9.5 Merck Animal Health Key News
8 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity, Analysis
    8.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity, 2017-2028
    8.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity of Key Manufacturers in Global Market
    8.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Non-steroidal Anti-inflammatory Drugs (NSAID) Supply Chain Analysis
    10.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Value Chain
    10.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Upstream Market
    10.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

List of Tables
    Table 1. Key Players of Non-steroidal Anti-inflammatory Drugs (NSAID) in Global Market
    Table 2. Top Non-steroidal Anti-inflammatory Drugs (NSAID) Players in Global Market, Ranking by Revenue (2021)
    Table 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Companies, (US$, Mn), 2017-2022
    Table 4. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Companies, 2017-2022
    Table 5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Companies, (K Units), 2017-2022
    Table 6. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Companies, 2017-2022
    Table 7. Key Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Price (2017-2022) & (USD/Unit)
    Table 8. Global Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Type
    Table 9. List of Global Tier 1 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2017-2022
    Table 13. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2023-2028
    Table 14. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2017-2022
    Table 15. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2023-2028
    Table 16. By Application – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2021 & 2028
    Table 17. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2017-2022
    Table 18. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2023-2028
    Table 19. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2017-2022
    Table 20. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2023-2028
    Table 21. By Region – Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2021 VS 2028
    Table 22. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2017-2022
    Table 23. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2023-2028
    Table 24. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2017-2022
    Table 25. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2023-2028
    Table 26. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2017-2022
    Table 29. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2023-2028
    Table 30. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2022
    Table 31. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2023-2028
    Table 32. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2017-2022
    Table 33. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2023-2028
    Table 34. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2022
    Table 35. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2023-2028
    Table 36. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2017-2022
    Table 37. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2023-2028
    Table 38. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2022
    Table 39. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2023-2028
    Table 40. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2017-2022
    Table 41. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2023-2028
    Table 42. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2022
    Table 43. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2023-2028
    Table 44. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2017-2022
    Table 45. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2023-2028
    Table 46. Bayer Corporate Summary
    Table 47. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
    Table 48. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 49. Ecotrin Corporate Summary
    Table 50. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
    Table 51. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 52. Generic Corporate Summary
    Table 53. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
    Table 54. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 55. St. Joseph Corporate Summary
    Table 56. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
    Table 57. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 58. Elanco Corporate Summary
    Table 59. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
    Table 60. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 61. Zoetis Corporate Summary
    Table 62. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
    Table 63. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 64. Boehringer Ingelheim Corporate Summary
    Table 65. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
    Table 66. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 67. Merial Corporate Summary
    Table 68. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
    Table 69. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 70. Merck Animal Health Corporate Summary
    Table 71. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
    Table 72. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 73. Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
    Table 74. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Capacity Market Share of Key Manufacturers, 2020-2022
    Table 75. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production by Region, 2017-2022 (K Units)
    Table 76. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production by Region, 2023-2028 (K Units)
    Table 77. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Opportunities & Trends in Global Market
    Table 78. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers in Global Market
    Table 79. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints in Global Market
    Table 80. Non-steroidal Anti-inflammatory Drugs (NSAID) Raw Materials
    Table 81. Non-steroidal Anti-inflammatory Drugs (NSAID) Raw Materials Suppliers in Global Market
    Table 82. Typical Non-steroidal Anti-inflammatory Drugs (NSAID) Downstream
    Table 83. Non-steroidal Anti-inflammatory Drugs (NSAID) Downstream Clients in Global Market
    Table 84. Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors and Sales Agents in Global Market
List of Figures
    Figure 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Type
    Figure 2. Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Application
    Figure 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2017-2028 (US$, Mn)
    Figure 7. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Global Market: 2017-2028 (K Units)
    Figure 8. The Top 3 and 5 Players Market Share by Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue in 2021
    Figure 9. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
    Figure 10. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
    Figure 11. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit), 2017-2028
    Figure 12. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
    Figure 13. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
    Figure 14. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit), 2017-2028
    Figure 15. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
    Figure 16. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
    Figure 17. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
    Figure 18. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
    Figure 19. US Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
    Figure 20. Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
    Figure 21. Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
    Figure 22. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
    Figure 23. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
    Figure 24. Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
    Figure 25. France Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
    Figure 26. U.K. Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
    Figure 27. Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
    Figure 28. Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
    Figure 29. Nordic Countries Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
    Figure 30. Benelux Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
    Figure 31. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
    Figure 32. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
    Figure 33. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
    Figure 34. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
    Figure 35. South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
    Figure 36. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
    Figure 37. India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
    Figure 38. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
    Figure 39. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
    Figure 40. Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
    Figure 41. Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
    Figure 42. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2017-2028
    Figure 43. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2017-2028
    Figure 44. Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
    Figure 45. Israel Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
    Figure 46. Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
    Figure 47. UAE Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2017-2028
    Figure 48. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity (K Units), 2017-2028
    Figure 49. The Percentage of Production Non-steroidal Anti-inflammatory Drugs (NSAID) by Region, 2021 VS 2028
    Figure 50. Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Value Chain
    Figure 51. Marketing Channels
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
70
Frequently Asked Questions
Non-steroidal Anti-inflammatory Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Non-steroidal Anti-inflammatory Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Non-steroidal Anti-inflammatory Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

DSLR Lenses Market

This report contains market size and forecasts of DSLR Lenses in global, including the following  ... Read More